Dalrada Financial Corporation

Equities

DFCO

US2354964031

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 03:38:43 2024-04-29 pm EDT			5-day change	1st Jan Change
0.1922 ^USD	+2.23%		+1.16%	-4.14%

Apr. 08	Dalrada Financial Corporation Subsidiary, Dalrada Home Corp., Forms Advisory Board and Announces Members	CI
Apr. 02	Dalrada Financial Corporation Announces Formation of Dalrada Home Inc. to Enter Home and Residential Heat Pump Market	CI

Dalrada Financial Corporation Reports Earnings Results for the Full Year Ended June 30, 2023

October 19, 2023 at 03:58 pm EDT

Dalrada Financial Corporation reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was USD 29.74 million compared to USD 19.27 million a year ago. Revenue was USD 29.74 million compared to USD 19.27 million a year ago.

Net loss was USD 20.29 million compared to USD 14.1 million a year ago. Basic loss per share from continuing operations was USD 0.24 compared to USD 0.2 a year ago. Diluted loss per share from continuing operations was USD 0.24 compared to USD 0.2 a year ago.

Latest news about Dalrada Financial Corporation

Dalrada Financial Corporation Subsidiary, Dalrada Home Corp., Forms Advisory Board and Announces Members	Apr. 08	CI
Dalrada Financial Corporation Announces Formation of Dalrada Home Inc. to Enter Home and Residential Heat Pump Market	Apr. 02	CI
Dalrada Financial Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14	CI
Dalrada Corporation Reports Revenue Results for the 2023	Feb. 13	CI
Dalrada Financial Corporation Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14	CI
Dalrada Financial Corporation Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-19	CI
Dalrada Financial Corporation Appoints Heather Mcmahon as A Member of the Board of Directors	23-10-06	CI
Dalrada Technology Spain Enters into an Agreement with Crown Glory Holding	23-09-07	CI
Dalrada Corporation Establishes Dalrada Technologies Morocco	23-08-29	CI
Dalrada Financial Corporation Announces Resignation of Anuradha Biswas as Director	23-08-08	CI
Dalrada?s Genefic Launches Achieve Weight-Loss and Wellness to Target Emerging Weight Loss Market	23-08-01	CI
Dalrada Financial Corporation Announces Executive Changes	23-07-13	CI
Dalrada Financial Corporation Expands its European Footprint Through Creation of Dalrada Technology Spain, S.L	23-07-11	CI
Dalrada Financial Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Dalrada Financial Corporation Announces Director Resignations	23-05-11	CI
Dalrada Corporation Signs Agreement with AKF Group for Clean Energy Efficiency Building Projects with an Estimated Value of More than $10 Million Annually	23-04-25	CI
Dalrada Financial Corporation Announces Retirement of Jose Arrieta as Director and Officer	23-04-24	CI
Dalrada Corporation Appoints Brian Murphy to Its Clean Energy Advisory Board	23-04-13	CI
Dalrada Financial Corporation Announces its Healthcare Division, Genefic Will Open New Location in North County San Diego	23-03-07	CI
Dalrada Financial Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-14	CI
Dalrada Financial Corporation Announces the Appointment of Harvey Hershkowitz as Chairman and CEO of Genefic	23-01-17	CI
Dalrada Financial Corporation Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-29	CI
Dalrada Financial Corporation Reports Earnings Results for the Full Year Ended June 30, 2022	22-11-01	CI
Dalrada Financial Corporation Auditor Raises 'Going Concern' Doubt	22-10-31	CI
Dalrada Financial Corporation acquired Bothof Brothers Construction Inc.	22-10-23	CI

Chart Dalrada Financial Corporation

Duration

Period

More charts

Company Profile

Dalrada Financial Corporation creates solutions, which directly address climate change, gaps in the healthcare industry and technology. The Company operates through four divisions: Genefic, Dalrada Energy Services (DES), Dalrada Precision Manufacturing, and Dalrada Technologies. Genefic delivers advanced healthcare solutions with dedicated products, services and systems. The division is engaged in the development of health products, lifesaving medications and building comprehensive systems. DES division operates as a single subsidiary, which provides end-to-end comprehensive energy service solutions in a robust commercial capacity. Dalrada Precision Manufacturing division creates total manufacturing solutions. Dalrada Technologies division creates digital products with computer information technology and software engineering services for a variety of technical industries and clients in both business-to-business (B2B) and business-to-customer (B2C) environments.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
DALRADA FINANCIAL CORPORATION	-4.14%	18.18M
ABBOTT LABORATORIES	-2.54%	187B
MEDTRONIC PLC	-1.85%	106B
BECTON, DICKINSON AND COMPANY	-4.26%	66.9B
DEXCOM, INC.	+1.39%	49.45B
CENCORA, INC.	+16.82%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.49%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+0.65%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution